S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization.
The present studies characterized the functional profile of N-[4-methoxy-3-(4-methylpiperazin-1-yl)phenyl]-1,2-dihydro-3-H-benzo[e]indole-3-carboxamide) (S32212), a combined serotonin (5-HT)(2C) receptor inverse agonist and α(2)-adrenoceptor antagonist that also possesses 5-HT(2A) antagonist propert...
Main Authors: | Dekeyne, A, Brocco, M, Loiseau, F, Gobert, A, Rivet, J, Di Cara, B, Cremers, T, Flik, G, Fone, K, Watson, D, Papp, M, Sharp, T, Serres, F, Cespuglio, R, Olivier, B, Chan, J, Lavielle, G, Millan, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2012
|
Similar Items
-
S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.
by: Dekeyne, A, et al.
Published: (2008) -
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole.
by: Millan, M, et al.
Published: (2004) -
Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.
by: Serres, F, et al.
Published: (2012) -
Blockade of α2-adrenoceptors induces Arc gene expression in rat brain in a glutamate receptor-dependent manner: a combined qPCR, in situ hybridisation and immunocytochemistry study.
by: Serres, F, et al.
Published: (2012) -
Effect of beta 2-adrenoceptor agonists on serotonin biochemistry and function.
by: Green, A, et al.
Published: (1984)